1697-1625 Screening compound: 5-{2-[(4Z)-5-oxo-1,3-diphenyl-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-1,2,3,4-tetrahydrophthalazine-1,4-dione

1697-1625 Screening compound: 5-{2-[(4Z)-5-oxo-1,3-diphenyl-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-1,2,3,4-tetrahydrophthalazine-1,4-dione
1697-1625 Screening compound: 5-{2-[(4Z)-5-oxo-1,3-diphenyl-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-1,2,3,4-tetrahydrophthalazine-1,4-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound 1697-1625
5-{2-[(4Z)-5-oxo-1,3-diphenyl-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-1,2,3,4-tetrahydrophthalazine-1,4-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

1697-1625

Molecular Formula

C23H16N6O3 (C23 H16 N6 O3)

Compound Name

5-{2-[(4Z)-5-oxo-1,3-diphenyl-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-1,2,3,4-tetrahydrophthalazine-1,4-dione

IUPAC name

5-{2-[(4Z)-5-oxo-13-diphenyl-45-dihydro-1H-pyrazol-4-ylidene]hydrazin-1-yl}-1234-tetrahydrophthalazine-14-dione

SMILES

O=C(/C1=N\Nc(cccc2C(NN3)=O)c2C3=O)N(c2ccccc2)N=C1c1ccccc1

InChI

InChI=1S/C23H16N6O3/c30-21-16-12-7-13-17(18(16)22(31)27-26-21)24-25-20-19(14-8-3-1-4-9-14)28-29(23(20)32)15-10-5-2-6-11-15/h1-13,24H,(H,26,30)(H,27,31)

InChI Key

LGAUPFRHNGMZDU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01078956

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

424.42

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.048

Distribution Coefficient, logD

3.048

Water Solubility, LogSw

-3.62

Polar Surface Area

99.878

Acid Dissociation Constant (pKa)

10.94

Base Dissociation Constant (pKb)

-5.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

1697-1625 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Antiviral Annotated Library (21441 compounds)

Frequent Hitters Library (7624 compounds)

Human Kinases Annotated Library (2415 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
Structure:
  • Pool

References: we are preparing a list of scientific research reports with 1697-1625 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 1697-1625?
Check Price and Availability of 1697-1625, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 1697-1625 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 1697-1625
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 1697-1625
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 1697-1625 available by request